Skip to main content
SABS logo

SABS · SAB Biotherapeutics, Inc. · Exempt Offerings

Track SABS — free
$3.41 -0.01 (-0.29%) At close · Sep 11
Market Cap
$310.26M
Shares
90.99M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2025-08-05 New $175,000,000 $175,000,000
2023-10-16 New $7,500,000 $7,500,000
Showing 1–2 of 2 filings
Key facts CIK 1833214 CUSIP 78397T202 13F (30d) 55 filings 55 filers Visit website Investor relations